Phase I/II study of bortezomib in combination with carboplatin and bevacizumab as first line therapy in patients with advanced non-small cell lung cancer (NSCLC)

af Piperdi, Bilal, Walsh, William V, Bradley, Kendra, Zhou, Zheng, Bathini, Venu, Hanrahan-Boshes, Meredith, Hutchinson, Lloyd, Perez-Soler, Roman
Udgivet 2012

Coordination and optimization of FDG PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination

af McIntosh, Lacey J., Rosen, Max P., Mittal, Kriti, Whalen, Giles F., Bathini, Venu G., Ali, Tasneem, Edmiston, Kathryn L., Walsh, William V., Gerber, Jonathan M.
Udgivet i Cancer Treat Rev (2021)

A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma

af Cetin, Volkan, Piperdi, Bilal, Bathini, Venu, Walsh, William V., Yunus, Shakeeb, Tseng, Jennifer F., Whalen, Giles F., Wassef, Wahid Y., Kadish, Sidney P., FitzGerald, Thomas J., Mikule, Christine, Wang, Yuxia, Grossman, Steven R.
Udgivet 2013

Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non–small-cell Lung Cancer

af Li, Tianhong, Piperdi, Bilal, Walsh, William V., Kim, Mimi, Beckett, Laurel A., Gucalp, Rasim, Haigentz, Missak, Bathini, Venu G., Wen, Huiyu, Zhou, Kaili, Pasquinelli, Patricia B., Gajavelli, Srikanth, Sreedhara, Meera, Xie, Xianhong, Lara, Primo N., Gandara, David R., Perez-Soler, Roman
Udgivet i Clin Lung Cancer (2016)